Market Movers: Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI), Zevra Therapeutics, Inc. (NASDAQ: ZVRA), and Leveraged ETFs Lead Today's Declines

• Despite recent product showcases, Faraday Future Intelligent Electric Inc. experienced a significant stock decline, suggesting broader investor concerns.
• Zevra Therapeutics, Inc. faced a sharp drop following a negative regulatory opinion from the European Medicines Agency regarding its drug arimoclomol.
• Leveraged and inverse exchange-traded funds (ETFs) amplified market movements, leading to substantial losses for some funds while indicating strong underlying asset performance for others.

The stock market experienced significant downward movements today, with several stocks and funds seeing sharp declines. Leading the market losers, Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) plummeted 39.63%, closing at $6.49. This occurred even as the electric vehicle and AI firm recently showcased its new robotics products at a community event, as highlighted by Business Wire.

Another major decliner was Zevra Therapeutics, Inc. (NASDAQ: ZVRA), which fell 23.92% to end the day at $9.53. According to Benzinga, the biopharmaceutical company's stock dropped after the European Medicines Agency's committee issued a negative opinion on its Marketing Authorization Application for the drug arimoclomol.

Leveraged exchange-traded funds (ETFs) also posted substantial losses. The GraniteShares 2x Long NBIS Daily ETF (NASDAQ: NBIL) dropped 30.15%, and the Leverage Shares 2x Long NBIS Daily ETF (NASDAQ: NBIG) fell 30.09%. These ETFs aim to deliver twice the daily return of Nebius Group N.V. stock, meaning they magnify both gains and losses.

Similarly, the Daily Target 2X Long HIMS ETF (NASDAQ: HIMZ) saw a 28.90% decline to $29.77. This is an inverse ETF, designed to provide two times the opposite (-200%) of the daily price change in Hims & Hers Health, Inc. (NYSE: HIMS) stock. The significant drop in HIMZ suggests the underlying Hims & Hers Health, Inc. stock had a strong positive performance today.

In summary, today's top market losers were driven by distinct factors. Regulatory news directly impacted Zevra Therapeutics, Inc.'s valuation, while the structure of leveraged and inverse ETFs led to amplified price swings based on the performance of their underlying assets. Faraday Future Intelligent Electric Inc.'s decline suggests investor concerns beyond its recent product activities.